The AHA Guidelines and Scientific Statements Handbook

(ff) #1
Index

Bartonella 318, 327–8
cause 314
culture-negative 321–2, 327, 329, 332
diagnosis 312
enterococcal 335
experimental 315, 332
infective 319–343
prophylaxis 333
prosthetic valve 293, 309, 319, 321, 325–6
enterococcal 322–5
valve
native 299 309
prosthetic 309–10
Endocrine disorders 211–2, 271, 282–3
Endocrinopathy 282
Endomyocardial fi brosis 241
Endothelin 226
Energy, estimated requirements 157
Enoxaparin 30, 32, 35–8, 42, 45, 63, 89, 127
ENRICHD Trial 221
Enterobacteriaceae 318
Enterococci 314, 316, 318, 322, 329–30
Epinephrine 75
Eplerenone 209–10, 227
Eprosartan 227
Epsilon-aminocaproic acid 141
Eptifi batide 35–7, 64, 130
Erythromycin 290
Erythropoiesis 232
Esmolol 209
Esophagogastroduodenoscopy 334
ESRD 134, 143, 219, 283, 291
Estrogens 192
Etexilate, dabigatran 254
European Atrial Fibrillation Trial 247–8
European Myocardial Infarction Amiodarone Trial 281
European Stroke Prevention Study 248
Event, thromboembolic 232
Evidence
-based grading system 332
pathological 313–4
serological 314
Exercise 6–8, 10–1, 296–7, 300–1, 303–5, 307
after cardiac rehabilitation 104
antiarrthymic effects of, after ICD 104
stress 299
testing 81, 270, 273–4, 298, 301
tolerance 305
training 98
Ezetimibe 190


Fabry disease 241
Fats, saturated 191, 218–9


Fatty acids 291
omega-3 67, 109, 217–8
polyunsaturated 189, 288
trans- 109, 189
Fenofi brate 190
Fibrate 192
Fibrillation 46, 65–6, 68, 74–5, 86
Fibrinolysis 52–3, 55–64, 68, 70, 72–3, 78–9, 82–3, 88,
124, 127
Fibroelastosis 241
First Line Radiofrequency Ablation versus Antiarrhythmic
Drugs for Atrial Fibrillation Treatment trial
254
Fistulae 316, 325
arteriovenous 344
Flecainide 249–51, 253, 259, 261–5, 267–8
5-fl uorouracil 291
Flutter, atrial 247, 252, 255, 257, 266–8, 291
Fluvastatin 190
Focal atrial tachycardias 256, 263–6
Focal junctional tachycardia 262
Folic acid 216, 220
Fondaparinux 26, 32, 35–8, 42, 45, 63, 68, 89, 127
Fosinopril 227
Framingham Heart Study 198, 205–6
Framingham Risk Score 198, 202, 205, 214–5, 338
Fugax 53
Function
impaired LV 275
renal 136
RV 274
ventricular 270, 274, 282, 289, 291
Furosemide 70, 228

Gallstones 190, 193
Gangrene 171, 182
Gaucher disease 241
Gemfi brozil 190
Genes 238–41
Genitourinary tract 332
Gentamicin 315, 317–24, 327–8
German Atrial Fibrillation Network 254
Global Registry of Acute Coronary Events 31
Glomerular fi ltration rate 202, 210–1
Glomerulonephritis 314
Glucocorticoid 140, 212
-remediable aldosteronism 212
Glucose 57, 64, 162, 193, 202
Glutaryl, hydroxymethyl 173
Glycohemoglobin 225
Glycoprotein 117
“golden hour” 50
Gout 190
Free download pdf